Journals / Turkish Journal of Hematology / 2016 / Cilt: 33 - Sayı: 1

Femoral Arter Kanamasında Ankaferd ve Chitosan İçeren Tamponların Hemostaz Üzerine Etkilerinin Deneysel Fare Modelinde Karşılaştırılması

Comparison of the Efficiencies of Buffers Containing Ankaferd and Chitosan on Hemostasis in an Experimental Rat Model with Femoral Artery Bleeding

Pages
48–52
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New studies are needed to evaluate the results of hypovolemic and hypotensive cases with major artery bleeding.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the first assessment of trauma patients with major vascular injuries, we need effective and rapid-acting homeostatic materials.
📊
Key Findings & Data:Materials and Methods: Thirty male Wistar albino rats weighing 200250 g were divided into 3 groups: control, Ankaferd, and chitosan.
💡
Conclusion & Impact:New studies are needed to evaluate the results of hypovolemic and hypotensive cases with major artery bleeding.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In the first assessment of trauma patients with major vascular injuries, we need effective and rapid-acting homeostatic materials. In this study we compare the efficiencies of Ankaferd Blood Stopper® and a chitosan linear polymer (Celox®) in an experimental rat model with femoral artery bleeding. Materials and Methods: Thirty male Wistar albino rats weighing 200250 g were divided into 3 groups: control, Ankaferd, and chitosan. The femoral artery and vein were visualized and bleeding was started by an incision. The bleeding time was recorded and categorized as 'bleeding stopped at the second minute', 'bleeding stopped at the fourth minute', and 'unsuccessful' if bleeding continued after the fourth minute.Results: In the control group, 60% of the bleeding did not stop. In the first 4 min in the Ankaferd group, the bleeding stopped in all rats; only in 1 of the rats in the chitosan group did the bleeding not stop. In stopping the bleeding in the first 4 min, Ankaferd was similar to chitosan but better than the control group; the chitosan group was similar to the control, but the p-value was close to significance. Conclusion: For major arterial bleeding, the main treatment is surgical bleeding control, but outside of the hospital we can use buffers containing Ankaferd and chitosan on the bleeding region. The results of this study should be supported with larger studies. Furthermore, in our study, healthy rats were used. New studies are needed to evaluate the results of hypovolemic and hypotensive cases with major artery bleeding.

Özet

Amaç: Büyük damar yaralanması olan travma hastalarının ilk müdahalesinde etkin ve hızlı etkili kanama durdurucu malzemelere ihtiyaç duyulmaktadır. Biz bu çalışmamızda, femoral arter kanamalı deneysel fare modelinde Ankaferd Blood Stopper® ve chitosan lineer polymerin (Celox®) etkinliklerini karşılaştırdık. Gereç ve Yöntem: Ağırlıkları 200-250 gram olan 30 erkek Wistar albino fare, kontrol, Ankaferd ve chitosan olmak üzere üç gruba ayrıldı. Femoral arter ve ven görünür hale getirildi ve bir kesi ile kanama başlatıldı. Kanama zamanı kaydedildi ve 'kanaması ilk iki dakikada duranlar', 'kanaması ilk dört dakikada duranlar' şeklinde ve eğer dördüncü dakikadan sonra kanama halen devam ediyorsa 'başarısız' olarak kaydedildi. Bulgular: Kontrol grubunda, kanamaların %60'ı durmadı. İlk dört dakikada Ankaferd grubunda tüm farelerde kanama durdu; chitosan grubunda sadece bir farede kanama durmadı. İlk dört dakikada kanamayı durdurmada Ankaferd, chitosan ile benzerdi fakat kontrol grubundan daha iyiydi; ayrıca chitosan kontrol grubuna benzerdi fakat p değeri anlamlılığa yakındı. Sonuç: Büyük arteryel kanamaların kontrolü için asıl tedavi cerrahi kanama kontrolüdür, fakat hastane dışı alanlarda Ankaferd ve chitosan içeren tamponlar kanama bölgesinde kullanılabilir. Araştırmamızın sonuçları daha geniş çalışmalarla desteklenmelidir. Ayrıca araştırmamızda sağlıklı fareler kullanılmıştır. Büyük arter kanamalı hipotansif ve hipovolemik olgulardaki sonuçları değerlendirmek için yeni çalışmalara ihtiyaç vardır.

🔖

Cite This Article

ABACIOĞLU, S., AYDIN, K., BÜYÜKCAM, F., KAYA, U., IŞIK, B., KARAKILIÇ, M. E. (2016). Femoral Arter Kanamasında Ankaferd ve Chitosan İçeren Tamponların Hemostaz Üzerine Etkilerinin Deneysel Fare Modelinde Karşılaştırılması. Turkish Journal of Hematology, Cilt: 33 - Sayı: 1, 48–52. https://ajindex.com/articles/413102

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Committee on Injury Prevention and Control. Reducing the Burden of Injury: Advancing Prevention and Treatment. Washington, DC, USA, National Academy Press, 1999.
  2. Brunett PH, Cameron PA. Trauma in adults. In: Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD, (eds). Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 17th ed. New York, NY, USA, McGraw Hill, 2010.
  3. Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther 2007;24:485-492.
  4. Ward KR, Tiba MH, Holbert WH, Blocher CR, Draucker GT, Proffitt EK, Bowlin GL, Ivatury RR, Diegelmann RF. Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 2007;63:276-283.
  5. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010;15:329-336.
  6. Uçar Albayrak C, Caliskan U, Haznedaroglu IC, Goker H. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008;36:1447-1448.
  7. Sonmez M, Baltacioğlu E, Sarac O, Erkut N. The use of Ankaferd blood stopper in a patient with Glanzmann's thrombasthenia with gingival bleeding. Blood Coagul Fibrinolysis 2010;21:382-383. Aydin S. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2009;37:279. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 2009;73:1742-1745.
  8. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010;267:1377-1381.
  9. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H, Kosar A, Aktas A, Captug O, Kurt M, Ozdemir O, Kirazli S, Firat HC. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost 2010;16:446-453.
  10. Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J 2010;31:864-868.
  11. Baykul T, Alanoglu EG, Kocer G. Use of Ankaferd Bl